EFNA3 and neoplasm: Hypoxic BrCa cells 4T1 release miR-210-containing EVs in the tumor microenvironment resulting in inhibition of Ephrin-A3 and Protein tyrosine phosphatase 1B (PTP1B), as well as in the increase of angiogenesis and tumor proliferation (98).